Nitroglycerin shortage has medical community worried

Nitroglycerin shortage has medical community worried

(HealthDay)—An ongoing shortage of the drug nitroglycerin is causing problems and concerns for doctors and hospitals in the United States. The drug is often the first therapy used by emergency room doctors when treating a heart attack patient.

"It's one of those drugs that in certain circumstances, there really is no substitute for," Frederick Blum, M.D., an emergency doctor who treats patients at Ruby Memorial Hospital in West Virginia, told The New York Times. He added that nitroglycerin supplies are so low that "if we had one or two patients that were really sick that needed extended drips, it could exhaust our supply pretty quickly."

Hospitals and doctors became concerned they might run out of the drug when Baxter International, the only U.S. manufacturer of injectable nitroglycerin, recently said it was slashing shipments of the drug, The Times reported.

This week, Baxter and the U.S. Food and Drug Administration said they were taking action to ease the shortage of nitroglycerin.

More information: Health Highlights: March 26, 2014

add to favorites email to friend print save as pdf

Related Stories

FDA takes action to ease neonatal drug shortage

May 29, 2013

(AP)—Federal health regulators will allow overseas imports of a critical intravenous drug formula used to nourish premature infants, amid a shortage that has impacted hospitals nationwide.

Recommended for you

Health care M&A leads global deal surge

Nov 23, 2014

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.